Clinical Trial Update: Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the efficacy and safety of an individualized dosing schedule of sunitinib in patients with metastatic clear cell renal cell carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Clear Cell, Metastatic Renal Cell Carcinoma | Phase 2 | Status: COMPLETED